ERIS — Eris Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Eris Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	R2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	873	1,504	860	965	2,079
Net Total Accounts Receivable
Net Total Receivables	2,191	2,713	4,593	4,276	4,644
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,670	6,273	7,647	23,020	12,230
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	779	1,919	3,774	5,393	6,621
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	18,348	22,721	36,673	70,405	70,332
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,669	1,996	4,432	25,321	13,814
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,584	3,638	14,713	44,543	41,788
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	15,764	19,083	21,960	25,862	28,544
Total Liabilities & Shareholders' Equity	18,348	22,721	36,673	70,405	70,332
Total Common Shares Outstanding